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BACKGROUND: The association between renal cell carcinoma (RCC) risk and family history of cancer has not been examined with an
adequate number of African Americans (AAs).
METHODS: In a population-based case–control study, unconditional logistic regression was used to calculate the association between
RCC risk and a family history of cancer among 1217 RCC cases and 1235 controls.
RESULTS: Increased RCC risk was shown for subjects with at least one first-degree relative with kidney cancer (odds ratio¼2.29; 95%
confidence interval¼1.31–4.00). No differences in risk were observed when analyses were stratified by race. For Caucasians, excess
risk was observed among those reporting a sibling with kidney cancer, whereas for AAs, increased risk occurred among subjects
reporting either a sibling or parent affected with the disease. A family history of non-renal cancers, and those related to smoking or to
the von Hippel–Lindau syndrome, revealed no association with RCC risk.
CONCLUSION: The RCC risk associated with a family history of kidney cancer is similar among Caucasians and AAs.
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In the United States, malignant tumours of the kidney account for
nearly 4% of cancer diagnoses and 2% of cancer deaths (Jemal
et al, 2009). Adenocarcinoma of the renal parenchyma (renal cell
carcinoma (RCC)) is the most common form, accounting for more
than 85% of kidney cancers (Chow and Devesa, 2008). Since 1950,
in the United States, there has been a 126% increase in RCC
incidence (Paglino et al, 2007), with higher rates reported among
African Americans (AAs) than among Caucasians (Chow and
Devesa, 2008). The increasing rates of RCC over time may reflect,
in part, the increasing use of imaging modalities (Paglino et al,
2007; Chow and Devesa, 2008; Patard, 2009). However, as the
increase involves all tumour sizes, not just those at the local
stage (Patard, 2009), imaging modalities alone do not entirely
explain the increase.
The aetiology of RCC is complex, with both environmental and
hereditary components suspected to have a role. Smoking, obesity,
and hypertension are primary risk factors that may explain half of all
RCC diagnoses in the United States (Benichou et al,1 9 9 8 ;C h o wa n d
Devesa, 2008). RCC risk has been examined in relation to familial
history of cancer in a number of epidemiological studies (McLaughlin
et al, 1984; Kreiger et al,1 9 9 3 ;G o l d g a ret al, 1994; Mellemgaard et al,
1994; Schlehofer et al, 1996; Gago-Dominguez et al, 2001; Czene and
Hemminki, 2002, 2003; Gudbjartsson et al, 2002; Negri et al,2 0 0 6 ;
Hung et al, 2007; Randi et al, 2007; Clague et al, 2009). Many of these
studies have shown a positive association with a family history of
cancer (Goldgar et al, 1994; Mellemgaard et al, 1994; Schlehofer et al,
1996; Gago-Dominguez et al, 2001), particularly when the affected
relative is a sibling (Czene and Hemminki, 2002; Gudbjartsson et al,
2002; Negri et al, 2006; Hung et al, 2007; Clague et al,2 0 0 9 ) .
Despite the racial disparity in RCC incidence, the numbers of AAs
studied have been insufficient to examine their risk separately. In a
recently completed population-based case–control study with a
relatively large number of AA subjects, we examined whether RCC
risk was elevated among participants with a history of cancer among
first-degree relatives, and whether risk varied by race.
MATERIALS AND METHODS
This population-based case–control study was conducted in
Chicago, IL, and in Detroit, MI. Cases were resident Caucasian
and AA men and women, aged 20–79 years, newly diagnosed with
RCC in Chicago from 1 January 2003 through to 31 December 2003
and in Detroit from 1 February 2002 through to 31 January 2007
for AAs and through to 31 July 2006 for Caucasians. All cases
had histologically confirmed adenocarcinoma of the kidney
(ICD-O C64). Controls selected from the general population were
frequency matched to cases on age, race, sex, and study centre.
Controls aged 65–79 years were identified from files of the Centers
for Medicare and Medicaid Services, and controls under the age of
65 years were identified from the Department of Motor Vehicle
(DMV) records. A sampling strategy was designed to increase the
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ynumber of AA participants used for analyses. All AA cases were
recruited, whereas some strata (age–race–sex combinations)
of Caucasian cases were subsampled. Controls were frequency
matched to cases at a 2:1 ratio for AAs and at a 1:1 ratio for
Caucasians. As information on race was unavailable from DMV
records, this hampered our ability to frequency match controls to
cases among those 20–64 years of age. Therefore, we used the
racial density of the census block group (according to the 2000
census), in which each control resided to serve as a surrogate for
race for the purposes of sampling. We oversampled people living
in high-density AA areas to help achieve the targeted matching
ratios for AAs.
Of 1918 eligible cases identified, 171 died before contact or
interview, 92 could not be located with the available contact
information, 21 moved out of the area, and the physicians of
63 cases refused permission to contact their patients. Among the
remaining 1571 cases we sought to enrol, 221 declined partici-
pation and 133 were not interviewed because of serious illness,
impairment, or failure to respond to multiple attempts to contact.
Thus, 1217 cases (77.5% of those we attempted to recruit)
participated in the study. Of 2718 presumed eligible controls,
41 died before contact or interview, 345 could not be located with
the available contact information, and 63 had moved out of the
region. Among the 2269 controls we attempted to recruit, 677
declined to participate and 357 were not interviewed because of
serious illness, impairment, or failure to respond to multiple
attempts to contact. Thus, 1235 eligible controls (54.4% of those we
attempted to recruit) participated. Institutional review board
approvals were obtained from all participating study centres and
informed written consent was obtained from all participants.
Trained interviewers were administered an in-home, computer-
assisted personal interview, in which detailed information was
collected on demographics, smoking history, medical and medica-
tion history, diet, occupation, and family history of cancer.
Information on family history of cancer was collected for all
first-degree relatives (parent, sibling, and offspring), including
cancer site and age at diagnosis. For analytical purposes, a set of
sample weights were developed to reduce the potential for bias
arising from differential sampling rates for controls and cases,
from survey non-response, and from deficiencies in the coverage
of the population at risk by the files of the DMV and Centers for
Medicare and Medicaid Services to select controls. For controls,
their sample weights also include a poststratification adjustment so
that the weighted distribution of controls across the matching
variables matches the weighted distribution of cases in an exact
manner. In addition to being consistent with the objectives of
frequency matching, this poststratification adjustment reduces the
variability of the weights compared with not using this adjustment
(Li et al, 2010).
The sample-weighted frequency distributions of selected charac-
teristics and known RCC risk factors were compared between
cases and controls using a Wald F-test. A w
2-test was also used
to compare the unweighted sample distribution of selected
characteristics in which similar findings were produced (data not
shown). Unconditional logistic regression models using poststra-
tified weights were used to calculate odds ratios (ORs) and 95%
confidence intervals (95% CIs) associated with a family history of
kidney cancer and a family history of non-renal cancers, using
subjects who did not have any family history of cancer as the
reference group. The jackknife replicate weight method was used
to estimate s.e. (Rust and Rao, 1996). Stratified analyses by race
were conducted, and interactions with race and family history were
tested using a t-test and a Wald test. Regression models
were adjusted for age at reference date (age at diagnosis for cases
and age at study selection for controls), sex, race, study centre,
education level, hypertension history (ever, never), family size
(defined as number of siblings and number of offspring), smoking
status, and body mass index. Unweighted unconditional logistic
regression analyses and tests for interactions comparing regression
models with and without interaction terms were also calculated, in
which results were similar to that of the weighted analysis (data
not shown). All analyses were conducted with STATA software
version 10.1 (StatCorp, 2007). Statistical tests were determined to
be significant at a two-sided P-value o0.05.
RESULTS
Overall, cases and controls were comparable in sex and age
distributions (Table 1). As expected, cases were more likely to
smoke, have hypertension, and have an excess body weight (body
mass index X30kgm
 2). Cases were more likely to have a lower
education level than controls. Similar distributions of charac-
teristics were observed when analyses were stratified by race.
A significant elevation in risk is shown in Table 2 among partici-
pants reporting at least one first-degree relative with kidney cancer
(OR¼2.29; 95% CI¼1.31–4.00). Analysis by relative type revealed
a non-significant increase in risk (OR¼1.45; 95% CI¼0.77–2.72)
when the affected relative was a parent; however, a significant
increase in risk was observed when a sibling was affected
(OR¼3.09; 95% CI¼1.33–7.20). Stratified analyses showed no
consistent differences in these associations by race, although the
estimated risk associated with a parent having had kidney cancer
was stronger among AAs (OR¼2.98; 95% CI¼1.06–8.37) than
among Caucasians (OR¼1.13; 95% CI¼0.50–2.58) (P-inter-
action¼0.19). A family history of non-renal cancers among first-
degree relatives was not associated with RCC risk, regardless
of whether family history was defined by relative type or stratified
by race.
RCC risk was comparable whether one (OR¼2.35; 95%
CI¼1.11–4.96) or more than one (OR¼2.23; 95% CI¼1.02–
4.88) first-degree relative was reported to have been diagnosed
with kidney cancer. The findings were similar when family history
of non-renal cancers was reported in one (OR¼0.93; 95%
CI¼0.75–1.14) compared with more than one (OR¼1.09; 95%
CI¼0.80–1.49) first-degree relative. No meaningful differences
in risk were observed with regard to relative type or race (data not
shown).
Because the von Hippel–Lindau syndrome is commonly linked
to inherited RCC, we examined the relationship between RCC risk
and a family history of several cancers that have been reported in
families with this syndrome (cancers of the retina, spinal cord,
brain stem, cerebellum, adrenal gland, pancreas, broad ligament,
and endolymphatic sac of the inner ear) (Kaelin, 2008).
No association was observed (OR¼0.99; 95% CI¼0.74–1.32).
A family history of smoking-related cancers (cancers of the lung,
bladder, breast, cervix, colon, oesophagus, larynx, pancreas,
stomach, oral cavity, and head and neck) was not related to RCC
risk (OR¼0.99; 95% CI¼0.83–1.19). No statistically significant
interactions between a family history of kidney cancer and
potential confounders (i.e., body mass index, age, sex, smoking
status, and hypertension history) were detected (data not shown).
No meaningful difference in association was revealed when
analyses were restricted to cases diagnosed with the clear-cell
subtype of RCC or with high-grade (Furhman nuclear grades III
and IV) tumours (data not shown).
DISCUSSION
This study confirms an association between RCC risk and a family
history of kidney cancer and, for the first time, shows that such
risk is comparable among Caucasians and AAs in the United
States. Among Caucasians, the excess risk was observed mainly in
individuals who reported having a sibling with kidney cancer;
among AAs, excess risk was seen whether the affected relative was
a sibling or a parent.
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history of kidney cancer in most previous case–control (Mellem-
gaard et al, 1994; Schlehofer et al, 1996; Gago-Dominguez et al,
2001; Negri et al, 2006; Clague et al, 2009) and cohort studies
(Goldgar et al, 1994; Czene and Hemminki, 2002; Gudbjartsson
et al, 2002; Clague et al, 2009), although results for some are null or
not statistically significant (McLaughlin et al, 1984; Kreiger et al,
1993; Hung et al, 2007; Randi et al, 2007). The reported excess
risks generally ranged from two- to five-fold for both study
designs. Most studies that have examined the type of first-degree
relative with kidney cancer reported a stronger renal cancer risk
if the affected relative was a sibling than a parent (Czene
and Hemminki, 2002; Gudbjartsson et al, 2002; Negri et al, 2006;
Hung et al, 2007). A recently published meta-analysis of seven
case–control studies and three cohort studies reported an overall
two-fold increase in RCC risk associated with a family history of
kidney cancer, and the risk was nearly four-fold when the affected
relative was a sibling (Clague et al, 2009). In this study, we also
observed a greater risk with a reported history of kidney cancer in
a sibling than in a parent, but this observation was confined to
Caucasians. Because of the relatively small numbers of subjects
with a family history of cancer, it is premature to conclude that
there are racial differences in RCC risk by the type of first-degree
relative affected with kidney cancer.
Elevated risk of sporadic RCC associated with a family history
of kidney cancer may indicate an inherited component in aetiology
or environmental exposures that are shared in families. Several
genetic syndromes predisposing to familial RCC have been
identified. The most common of the hereditary syndromes are
germline mutations in the von Hippel–Lindau (VHL) tumour-
suppressor gene on chromosome 3p, which is associated
exclusively with the clear cell histological subtype (Czene and
Hemminki, 2002; Hung et al, 2007; Chow and Devesa, 2008). In
addition to RCC, individuals with this germline mutation are at an
increased risk for developing tumours of the central nervous
system, retina, endolymphatic sac of the inner ear, broad ligament,
Table 1 Weighted characteristics of participants
All participants Caucasian participants African-American participants
Cases Controls Cases Controls Cases Controls
Variables N %
a N %
a P-value
b N %
a N %
a P-value
b N %
a N %
a P-value
b
Total 1217 1235 856 712 361 523
Sex
Males 720 61.8 689 61.4 495 62.0 439 61.6 225 61.3 250 60.8
Females 497 38.2 546 38.6 0.10 361 38.0 273 38.4 0.07 136 38.8 273 39.2 0.54
Age at reference date (years)
o45 147 10.5 179 10.5 106 10.2 93 10.2 41 11.6 86 11.6
45–54 287 21.6 270 21.6 185 20.0 145 20.0 102 26.1 125 26.1
55–64 372 29.4 350 29.4 255 29.1 205 29.1 117 30.2 145 30.2
65–74 303 27.1 329 27.1 221 28.1 196 28.1 82 24.3 133 24.3
75+ 108 11.5 107 11.5 o0.99 89 12.7 73 12.7 o0.99 19 7.9 34 7.9 o0.99
Mean age (years) 59.9 59.9 60.5 60.4 58.5 58.4
Study center
Detroit 1018 83.3 1038 82.7 738 84.9 611 83.9 280 78.6 427 79.0
Chicago 199 16.7 197 17.3 0.57 118 15.1 101 16.1 0.50 81 21.4 96 21.0 0.88
BMI
c
o25 240 19.5 366 29.1 172 19.6 216 29.4 68 19.1 150 28.1
25–29.9 436 37.4 493 41.7 310 37.7 294 42.3 126 36.8 199 40.0
30–34.99 298 24.9 221 18.3 210 25.2 126 18.1 88 23.9 95 18.9
35+ 230 18.2 147 10.9 o0.001 156 17.6 74 10.1 o0.001 74 20.2 73 13.1 0.01
Smoking status
Never 432 35.3 471 38.4 309 35.8 287 39.9 123 33.9 184 34.3
Occasional
d 55 4.7 55 4.0 34 4.2 25 3.5 21 6.2 30 5.4
Regular former smoker 410 34.7 445 38.0 304 36.5 276 39.3 106 29.4 169 34.1
Regular current smoker 320 25.3 264 19.7 0.03 209 23.5 124 17.4 0.05 111 30.5 140 26.3 0.25
History of hypertension
No 500 40.8 718 59.0 398 45.1 445 61.7 102 28.8 273 51.3
Yes 701 59.2 508 41.0 o0.001 445 55.0 262 38.3 o0.001 256 71.2 246 48.7 o0.001
Education level
o12 years 200 16.7 165 12.0 103 12.7 65 9.4 97 28.1 100 19.1
High school graduate 419 34.5 390 31.5 315 36.6 214 30.8 104 28.7 176 33.5
Some college 328 26.3 356 27.3 215 24.9 184 25.6 113 30.3 172 32.1
College graduate 270 22.5 324 29.3 o0.001 223 25.9 249 34.2 0.001 47 12.8 75 15.3 0.01
Abbreviation: BMI¼body mass index.
aA sample-weighted frequency distribution.
bP-value from sample Wald F-test.
cBMI 5 years before interview.
dSmoked 100 cigarettes
in the lifetime, but never smoked at least 1 cigarette a day for 6 months or longer. The following data are unknown: BMI (eight Caucasian cases, two Caucasian controls,
five African-American cases, six African-American controls), history of hypertension (thirteen Caucasian cases, five Caucasian controls, three African-American cases,
four African-American controls).
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observe an association with a history of any of these VHL-related
tumours among first-degree relatives. Shared environmental
exposures among family members may also have a role in the
associations observed in this study. We were unable to obtain
exposure information for relatives of study participants or
information on exposures during childhood; however, adjustment
for known RCC risk factors, including smoking, obesity, and
hypertension, did not modify the association between RCC risk
and familial history of cancer. Until twin studies are conducted, it
will be difficult to dissect the relative contributions of genetic
factors and shared environmental exposures among family
members on sporadic RCC risk. The largest published twin study
has been uninformative on kidney cancer risk because of the lack
of concordant twin pairs (Lichtenstein et al, 2000).
This is the first RCC case–control study to include a sufficient
number of AAs to evaluate their risks separately. Histologically
confirmed cancer and a large sample size are strengths, but power
for stratified analysis was limited. The response rate among controls
was not optimal (54.4%); however, the weighting strategies used in
this study allowed for analyses that were more robust to non-
response and the power for stratified analyses was limited. We did
not verify the self-reported history of kidney cancer among first-
degree relatives, and recall may have been more accurate among
cases than among controls. However, we believe this to be unlikely as
no association with an increasing number of affected first-degree
relatives with kidney cancer was observed.
This study finds that family history of kidney cancer among
first-degree relatives is associated with a significantly increased
RCC risk, and that risk is similar in Caucasians and AAs.
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